Point-of-Care Diagnostic Technologies for Antimicrobial Resistance: Principles, Platforms, Clinical Impact, and Future Directions
Diagnostics · 21.04.2026 · 16 (8) · 1239
DOI: 10.3390/diagnostics16081239 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 21.04.2026. Verfasst von Nahed N Mahrous und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, College of Science, University of Hafr Al-Batin, Hafr Al-Batin 39524, Saudi Arabia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance (AMR) is an ever-growing threat to global healthcare. It is largely driven by delayed or inadequate pathogen identification and antimicrobial susceptibility testing in routine clinical workflows. By the time the clinician receives results to guide treatment from traditional culture-based diagnostics, several days may have elapsed, leading to the use and potential over-prescription of broad-spectrum antibiotics and the development of resistant pathogens. A rapid and clinically actionable diagnostic approach at the clinical point of care (POC) may help address this gap. This review examines current and emerging POC diagnostic technologies for AMR and outlines the fundamental principles and mechanistic classifications of POC diagnostic technologies. These include phenotypic, genotypic, immunological, and biosensor-based approaches. A critical overview of key technological platforms, including rapid phenotypic antimicrobial susceptibility testing (AST), microfluidics and isothermal nucleic acid amplification (e.g., LAMP and RPA), CRISPR-based diagnostics, nanomaterial-enhanced biosensors, and mobile-integrated systems is provided. The impact of POC diagnostics on antimicrobial stewardship, time to appropriate therapy, and patient outcomes in primary care settings, hospitals, intensive care units, and resource-limited settings is presented and discussed. In addition to clinical implementation challenges, this review considers the issues of analytical performance, workflow, regulatory pathways, cost, and implementation readiness. In addition, it outlines key trends regarding digital integration, surveillance, workforce training, and policy frameworks. Overall, the review outlines the role of POC diagnostics in enhancing antimicrobial response surveillance and the global fight against AMR. Among emerging platforms, rapid phenotypic AST, microfluidic and isothermal-based assays, CRISPR-based diagnostics, and integrated biosensor systems show the greatest potential for near-term clinical impact; however, widespread implementation remains constrained by challenges related to clinical validation, cost, workflow integration, and alignment with antimicrobial stewardship frameworks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, College of Science, University of Hafr Al-Batin, Hafr Al-Batin 39524, Saudi Arabia.
- Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Medina 42353, Saudi Arabia.
- Applied Genomics Technologies Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
ORCID-Profile: Esraa A Aldkheil, Yahya F Jamous
Zitieren
APA
Mahrous, N. N., Fallatah, M. M., Fitaihi, R. A., Aldahshan, H., Alhhazmi, A. A., Al-Khaldi, S., Fallatah, H., Althobaiti, A. A., Alkhoshaiban, A. S., Alguraini, J., Aldkheil, E. A., & Jamous, Y. F. (2026). Point-of-Care Diagnostic Technologies for Antimicrobial Resistance: Principles, Platforms, Clinical Impact, and Future Directions. Diagnostics, 16(8), 1239. https://doi.org/10.3390/diagnostics16081239
Vancouver
Mahrous NN, Fallatah MM, Fitaihi RA, Aldahshan H, Alhhazmi AA, Al-Khaldi S, et al. Point-of-Care Diagnostic Technologies for Antimicrobial Resistance: Principles, Platforms, Clinical Impact, and Future Directions. Diagnostics. 2026;16(8):1239. doi:10.3390/diagnostics16081239
BibTeX
@article{Mahrous2026,
author = {Mahrous, Nahed N and Fallatah, Mohannad M and Fitaihi, Rawan A and Aldahshan, Hala and Alhhazmi, Areej A and Al-Khaldi, Samiyah and Fallatah, Hussam and Althobaiti, Abdulmajeed A and Alkhoshaiban, Abdulaziz Saleh and Alguraini, Jawaher and Aldkheil, Esraa A and Jamous, Yahya F},
title = {Point-of-Care Diagnostic Technologies for Antimicrobial Resistance: Principles, Platforms, Clinical Impact, and Future Directions},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {8},
pages = {1239},
doi = {10.3390/diagnostics16081239}
}
EUVIMED